-
1
-
-
0031949858
-
Combination therapy in rheumatoid arthritis: Updated systematic review
-
Verhoeven AC, Boers M, Tugwell P. Combination therapy in rheumatoid arthritis: Updated systematic review. Br J Rheumatol 1998;37:612-9.
-
(1998)
Br J Rheumatol
, vol.37
, pp. 612-619
-
-
Verhoeven, A.C.1
Boers, M.2
Tugwell, P.3
-
2
-
-
0031950185
-
Methotrexate in rheumatoid arthritis: An update with focus on mechanisms involved in toxicity
-
van Ede AE, Laan RFJM, Blom HJ, De Abreu RA, van de Putte LBA. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum 1998; 27:277-92.
-
(1998)
Semin Arthritis Rheum
, vol.27
, pp. 277-292
-
-
Van Ede, A.E.1
Laan, R.F.J.M.2
Blom, H.J.3
De Abreu, R.A.4
Van De Putte, L.B.A.5
-
3
-
-
0028874225
-
Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: Association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy
-
Kremer JM, Petrillo GF, Hamilton RA. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: Association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy. J Rheumatol 1995;22:38-40.
-
(1995)
J Rheumatol
, vol.22
, pp. 38-40
-
-
Kremer, J.M.1
Petrillo, G.F.2
Hamilton, R.A.3
-
4
-
-
0027171787
-
Renal effects of low-dose methotrexate in rheumatoid arthritis
-
Seideman P, Müller-Suur R, Ekman E. Renal effects of low-dose methotrexate in rheumatoid arthritis. J Rheumatol 1993;20:1126-8.
-
(1993)
J Rheumatol
, vol.20
, pp. 1126-1128
-
-
Seideman, P.1
Müller-Suur, R.2
Ekman, E.3
-
5
-
-
0027478126
-
Renal toxicity of the nonsteroidal antiinflammatory drugs
-
Murray MD, Brater DC. Renal toxicity of the nonsteroidal antiinflammatory drugs. Annu Rev Pharmacol Toxicol 1993; 33:435-65.
-
(1993)
Annu Rev Pharmacol Toxicol
, vol.33
, pp. 435-465
-
-
Murray, M.D.1
Brater, D.C.2
-
7
-
-
0025989927
-
Low dose MTX and NSAID induced mild renal insufficiency and severe neutropenia
-
Kraus A, Alarcon-Segovia D. Low dose MTX and NSAID induced mild renal insufficiency and severe neutropenia [letter]. J Rheumatol 1991;18:1274.
-
(1991)
J Rheumatol
, vol.18
, pp. 1274
-
-
Kraus, A.1
Alarcon-Segovia, D.2
-
8
-
-
0027364975
-
Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate
-
Rooney TW, Furst DE, Koehnke R, Burmeister L. Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate. J Rheumatol 1993;20:1297-302.
-
(1993)
J Rheumatol
, vol.20
, pp. 1297-1302
-
-
Rooney, T.W.1
Furst, D.E.2
Koehnke, R.3
Burmeister, L.4
-
9
-
-
0029924144
-
Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate
-
Franck H, Rau R, Herborn G. Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate. Clin Rheumatol 1996;15:429-30.
-
(1996)
Clin Rheumatol
, vol.15
, pp. 429-430
-
-
Franck, H.1
Rau, R.2
Herborn, G.3
-
10
-
-
0026502732
-
The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis
-
Tracy TS, Krohn K, Jones DR, Bradley JD, Hall SD, Brater DC. The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis. Eur J Clin Pharmacol 1992;42:121-5.
-
(1992)
Eur J Clin Pharmacol
, vol.42
, pp. 121-125
-
-
Tracy, T.S.1
Krohn, K.2
Jones, D.R.3
Bradley, J.D.4
Hall, S.D.5
Brater, D.C.6
-
11
-
-
0026570125
-
Methotrexate and nonsteroidal antiinflammatory drug interactions
-
Frenia ML, Long KS. Methotrexate and nonsteroidal antiinflammatory drug interactions. Ann Pharmacother 1992;26:234-7.
-
(1992)
Ann Pharmacother
, vol.26
, pp. 234-237
-
-
Frenia, M.L.1
Long, K.S.2
-
12
-
-
0025678922
-
Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis
-
Fries JF, Singh G, Lenert L, Furst DE. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum 1990;33:1611-9.
-
(1990)
Arthritis Rheum
, vol.33
, pp. 1611-1619
-
-
Fries, J.F.1
Singh, G.2
Lenert, L.3
Furst, D.E.4
-
13
-
-
0025269503
-
Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis
-
Stewart CF, Fleming RA, Arkin CR, Evans WE. Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis. Clin Pharmacol Ther 1990;47:540-6.
-
(1990)
Clin Pharmacol Ther
, vol.47
, pp. 540-546
-
-
Stewart, C.F.1
Fleming, R.A.2
Arkin, C.R.3
Evans, W.E.4
-
14
-
-
0025125626
-
Lack of significant interaction between low-dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis
-
Skeith KJ, Russell AS, Jamali F, Coates J, Friedman H. Lack of significant interaction between low-dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis. J Rheumatol 1990; 17:1008-10.
-
(1990)
J Rheumatol
, vol.17
, pp. 1008-1010
-
-
Skeith, K.J.1
Russell, A.S.2
Jamali, F.3
Coates, J.4
Friedman, H.5
-
15
-
-
0025160135
-
Effect of aspirin and sulindac on methotrexate clearance
-
Furst DE, Herman RA, Koehnke R, et al. Effect of aspirin and sulindac on methotrexate clearance. J Pharmacol Sci 1990;79:782-6.
-
(1990)
J Pharmacol Sci
, vol.79
, pp. 782-786
-
-
Furst, D.E.1
Herman, R.A.2
Koehnke, R.3
-
16
-
-
0026348698
-
Aspirin alters methotrexate disposition in rheumatoid arthritis patients
-
Stewart CF, Fleming RA, Germain BF, Seleznick MJ, Evans WE. Aspirin alters methotrexate disposition in rheumatoid arthritis patients. Arthritis Rheum 1991;34:1514-20.
-
(1991)
Arthritis Rheum
, vol.34
, pp. 1514-1520
-
-
Stewart, C.F.1
Fleming, R.A.2
Germain, B.F.3
Seleznick, M.J.4
Evans, W.E.5
-
17
-
-
0028297915
-
Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis
-
Anaya J, Fabre D, Bressolle F. et al. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis. J Rheumatol 1994;21:203-8.
-
(1994)
J Rheumatol
, vol.21
, pp. 203-208
-
-
Anaya, J.1
Fabre, D.2
Bressolle, F.3
-
18
-
-
0029053714
-
Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients
-
Combe B, Edno L, Lafforgue P, et al. Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients. Br J Rheumatol 1995;34:421-8.
-
(1995)
Br J Rheumatol
, vol.34
, pp. 421-428
-
-
Combe, B.1
Edno, L.2
Lafforgue, P.3
-
19
-
-
0028792273
-
The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: Impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg
-
Kremer JM, Hamilton RA. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg. J Rheumatol 1995;22:2072-7.
-
(1995)
J Rheumatol
, vol.22
, pp. 2072-2077
-
-
Kremer, J.M.1
Hamilton, R.A.2
-
20
-
-
1842299887
-
Lack of pharmacokinetic interaction of meloxicam with methotrexate in patients with rheumatoid arthritis
-
Hubner G, Sander O, Degner FL, Turck D, Rau R. Lack of pharmacokinetic interaction of meloxicam with methotrexate in patients with rheumatoid arthritis. J Rheumatol 1997;24:845-51.
-
(1997)
J Rheumatol
, vol.24
, pp. 845-851
-
-
Hubner, G.1
Sander, O.2
Degner, F.L.3
Turck, D.4
Rau, R.5
-
21
-
-
0027986841
-
Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs
-
Laneuville O, Breuer DK, DeWitt DL, Hla T, Funk CD, Smith WL. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 1994;271:927-34.
-
(1994)
J Pharmacol Exp Ther
, vol.271
, pp. 927-934
-
-
Laneuville, O.1
Breuer, D.K.2
Dewitt, D.L.3
Hla, T.4
Funk, C.D.5
Smith, W.L.6
-
22
-
-
0030017042
-
Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts
-
Kargman S, Charleson S, Cartwright M, et al. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 1996;111:445-54.
-
(1996)
Gastroenterology
, vol.111
, pp. 445-454
-
-
Kargman, S.1
Charleson, S.2
Cartwright, M.3
-
23
-
-
0025754779
-
Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
-
Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-6.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 2692-2696
-
-
Xie, W.1
Chipman, J.G.2
Robertson, D.L.3
Erikson, R.L.4
Simmons, D.L.5
-
24
-
-
0025871150
-
TIS10, a phorbol ester tumor promoter-inducible mRNA from swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
-
Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866-72.
-
(1991)
J Biol Chem
, vol.266
, pp. 12866-12872
-
-
Kujubu, D.A.1
Fletcher, B.S.2
Varnum, B.C.3
Lim, R.W.4
Herschman, H.R.5
-
25
-
-
0031679914
-
Interspecies differences in renal localization of cyclooxygenase isoforms: Implications in nonsteroidal antiinflammatory drug-related nephrotoxicity
-
Khan KNM, Venturini CM, Bunch RT, et al. Interspecies differences in renal localization of cyclooxygenase isoforms: Implications in nonsteroidal antiinflammatory drug-related nephrotoxicity. Toxicol Pathol 1998;26:612-20.
-
(1998)
Toxicol Pathol
, vol.26
, pp. 612-620
-
-
Khan, K.N.M.1
Venturini, C.M.2
Bunch, R.T.3
-
26
-
-
13444266910
-
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cylooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-l-yl] benzenesulfonamide (SC-58635, celecoxib)
-
Penning TD, Talley JJ, Bertenshaw SR, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cylooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-l-yl] benzenesulfonamide (SC-58635, celecoxib). J Med Chem 1997;40:1347-65.
-
(1997)
J Med Chem
, vol.40
, pp. 1347-1365
-
-
Penning, T.D.1
Talley, J.J.2
Bertenshaw, S.R.3
-
27
-
-
0031680203
-
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects
-
Simon LS, Lanza FL, Lipsky PE, et al. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum 1998;41:1591-602.
-
(1998)
Arthritis Rheum
, vol.41
, pp. 1591-1602
-
-
Simon, L.S.1
Lanza, F.L.2
Lipsky, P.E.3
-
28
-
-
0030787861
-
Outcome of specific COX-2 inhibition in rheumatoid arthritis
-
Lipsky PE. Isakson PC. Outcome of specific COX-2 inhibition in rheumatoid arthritis. J Rheumatol 1997;24 Suppl 49:9-14.
-
(1997)
J Rheumatol
, vol.24
, Issue.SUPPL. 49
, pp. 9-14
-
-
Lipsky, P.E.1
Isakson, P.C.2
-
29
-
-
0023853643
-
Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis
-
Weinblatt ME, Trentham DE, Fraser PA, et al. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:167-75.
-
(1988)
Arthritis Rheum
, vol.31
, pp. 167-175
-
-
Weinblatt, M.E.1
Trentham, D.E.2
Fraser, P.A.3
-
30
-
-
0024400067
-
Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment
-
Alarcon GS, Tracy IC, Blackburn WD Jr. Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 1989;32:671-6.
-
(1989)
Arthritis Rheum
, vol.32
, pp. 671-676
-
-
Alarcon, G.S.1
Tracy, I.C.2
Blackburn W.D., Jr.3
-
31
-
-
84960561529
-
Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis
-
Furst DE. Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis. Br J Rheumatol 1995;34 Suppl 2:20-5.
-
(1995)
Br J Rheumatol
, vol.34
, Issue.SUPPL. 2
, pp. 20-25
-
-
Furst, D.E.1
-
32
-
-
0033524421
-
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
-
McAdam BF, Catella-Lawson F, Mardini IA, et al. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 1999;96:272-7.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 272-277
-
-
McAdam, B.F.1
Catella-Lawson, F.2
Mardini, I.A.3
-
33
-
-
0021359905
-
Nonlinear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption
-
Hendel J. Nyfors A. Nonlinear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption. Eur J Clin Pharmacol 1984;26:121-4.
-
(1984)
Eur J Clin Pharmacol
, vol.26
, pp. 121-124
-
-
Hendel, J.1
Nyfors, A.2
|